BG104988A - N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори - Google Patents
N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори Download PDFInfo
- Publication number
- BG104988A BG104988A BG104988A BG10498800A BG104988A BG 104988 A BG104988 A BG 104988A BG 104988 A BG104988 A BG 104988A BG 10498800 A BG10498800 A BG 10498800A BG 104988 A BG104988 A BG 104988A
- Authority
- BG
- Bulgaria
- Prior art keywords
- compound
- formula
- disorders
- drug
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
| PCT/EP1999/003648 WO1999062902A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104988A true BG104988A (bg) | 2001-11-30 |
Family
ID=10833098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104988A BG104988A (bg) | 1998-06-03 | 2000-11-27 | N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1087964A1 (pt) |
| JP (1) | JP2002517392A (pt) |
| KR (1) | KR20010052526A (pt) |
| CN (1) | CN1304408A (pt) |
| AR (1) | AR018622A1 (pt) |
| AU (1) | AU4369599A (pt) |
| BG (1) | BG104988A (pt) |
| BR (1) | BR9910927A (pt) |
| CA (1) | CA2333756A1 (pt) |
| CO (1) | CO5021190A1 (pt) |
| GB (1) | GB9811879D0 (pt) |
| HR (1) | HRP20010005A2 (pt) |
| HU (1) | HUP0102233A2 (pt) |
| ID (1) | ID27067A (pt) |
| IL (1) | IL139552A0 (pt) |
| NO (1) | NO20006041L (pt) |
| PL (1) | PL344594A1 (pt) |
| SK (1) | SK17602000A3 (pt) |
| TR (1) | TR200003569T2 (pt) |
| WO (1) | WO1999062902A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
| AU2001267421A1 (en) * | 2000-05-12 | 2001-11-20 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
| ATE255578T1 (de) * | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | Piperazin- und piperidinverbindungen |
| GT200600078A (es) | 2005-02-17 | 2007-04-12 | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
-
1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
-
1999
- 1999-05-26 IL IL13955299A patent/IL139552A0/xx unknown
- 1999-05-26 CN CN99806908A patent/CN1304408A/zh active Pending
- 1999-05-26 EP EP99926434A patent/EP1087964A1/en not_active Ceased
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/hu unknown
- 1999-05-26 ID IDW20002519A patent/ID27067A/id unknown
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/en not_active Application Discontinuation
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/xx unknown
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/ja active Pending
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/pt not_active IP Right Cessation
- 1999-05-26 PL PL99344594A patent/PL344594A1/xx not_active Application Discontinuation
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/ko not_active Application Discontinuation
- 1999-05-26 CA CA002333756A patent/CA2333756A1/en not_active Abandoned
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/sk unknown
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-06-03 AR ARP990102619A patent/AR018622A1/es not_active Application Discontinuation
- 1999-06-03 CO CO99035020A patent/CO5021190A1/es unknown
-
2000
- 2000-11-27 BG BG104988A patent/BG104988A/bg unknown
- 2000-11-29 NO NO20006041A patent/NO20006041L/no not_active Application Discontinuation
-
2001
- 2001-01-02 HR HR20010005A patent/HRP20010005A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU4369599A (en) | 1999-12-20 |
| JP2002517392A (ja) | 2002-06-18 |
| NO20006041D0 (no) | 2000-11-29 |
| CO5021190A1 (es) | 2001-03-27 |
| SK17602000A3 (sk) | 2001-08-06 |
| AR018622A1 (es) | 2001-11-28 |
| PL344594A1 (en) | 2001-11-05 |
| HUP0102233A2 (hu) | 2002-05-29 |
| WO1999062902A1 (en) | 1999-12-09 |
| IL139552A0 (en) | 2002-02-10 |
| CA2333756A1 (en) | 1999-12-09 |
| NO20006041L (no) | 2000-11-29 |
| BR9910927A (pt) | 2001-02-20 |
| GB9811879D0 (en) | 1998-07-29 |
| EP1087964A1 (en) | 2001-04-04 |
| HRP20010005A2 (en) | 2001-12-31 |
| TR200003569T2 (tr) | 2001-04-20 |
| KR20010052526A (ko) | 2001-06-25 |
| CN1304408A (zh) | 2001-07-18 |
| ID27067A (id) | 2001-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2136680C1 (ru) | Производные амина и фармацевтическая композиция на их основе | |
| Evans et al. | Synthesis and antihypertensive activity of substituted trans-4-amino-3, 4-dihydro-2, 2-dimethyl-2H-1-benzopyran-3-ols | |
| EP0241053B1 (en) | Aryl-substituted (n-piperidinyl)-methyl- and (n-piperazinyl) methylazoles having antipsychotic properties | |
| TWI310035B (en) | Muscarinic agonists | |
| JP5290964B2 (ja) | 新規１，４−ジアザ−ビシクロ［３．２．２］ノニルオキサジアゾリル誘導体及びそれらの医学的使用 | |
| HUE027746T2 (en) | Piperazine-substituted benzothiophene derivatives as antipsychotic agents | |
| KR20020067589A (ko) | 페닐피페라지닐 유도체 | |
| JP2003521443A (ja) | ４，５，６及び７−インドール及びインドリン誘導体、その製造方法及びその使用方法 | |
| JP2003519224A (ja) | 置換されたフェニル−ピペラジン誘導体、その製造方法及びその使用方法 | |
| HU189174B (en) | Process for the production of trans-2-substituted-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/ indol derivatives | |
| JPH07188207A (ja) | １−［２ｈ−１−ベンゾピラン−２−オン−８−イル］−ピペラジン誘導体 | |
| JP2010536724A (ja) | ニコチン性アセチルコリン受容体リガンドとして有用な１，４−ジアザ−ビシクロ（３．２．２）ノニルピリミジニル誘導体 | |
| BG104988A (bg) | N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори | |
| US20040039023A1 (en) | Therapeutic agents | |
| JP2001508419A (ja) | ５−ｈｔ受容体活性を有するスルホンアミド化合物 | |
| US5229412A (en) | Method for relieving anxiety using 5-hydroxytryptamine-1a-receptor-binding compounds | |
| JP3761796B2 (ja) | 新規ヘテロシクロアルキルベンゾシクロブタン及びヘテロアリールベンゾシクロブタン化合物、その製造法、並びにそれを含有する医薬組成物 | |
| AU761122B2 (en) | Aryl-(4-flouro-4-((2-pyridin-2-yl-ethylamino)-methyl)- piperidin-1-yl)-methanone derivatives as 5-HT1 receptor antagonists | |
| JP2001512491A (ja) | １−（イソキノリン−１−イル）−４−（１−フェニメチル）ピペラジン；ドーパミン受容体サブタイプ特異的リガンド | |
| CN1051085C (zh) | 取代的二氢吡喃并吡啶及其制法、用途和含其的药物组合物 | |
| MXPA00011523A (es) | Agentes terapeuticos | |
| JPS59141565A (ja) | 向精神性活性を有するピリダジン誘導体，その製造方法および該誘導体を含有する薬剤 | |
| JPS62221683A (ja) | 芳香族ω−アルキルイミノテトラヒドロ−６Ｈ−１，３−チアジン−６−オン誘導体 | |
| CZ20004461A3 (cs) | Terapeutické činidlo | |
| JP2010535175A (ja) | Ｎ−アリール−ｎ−ピペリジン−４−イルメチルアミド誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのその使用 |